Domenica Marie Rubino, M.D.
Opted out of Medicare from December 2017 to December 2027. Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Arlington, Virginia, licensed in VA and DC, with an NPI issued in January 2007. Part D covered 242 prescriptions written in 2024, 51% of them generic. Novo Nordisk Inc was the largest of 12 companies reporting payments in 2025, $109,587 in all, mostly consulting fees.
Overview
| NPI | 1639226236 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jan 4, 2007 |
| Last updated in NPPES | Sep 23, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 0101222197 | VA |
| Internal Medicine, Endocrinology, Diabetes & Metabolism | 207RE0101X | MD32032 | DC |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Dec 21, 2017 – Dec 21, 2027 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 242 · 499 30-day fills |
|---|---|
| Patients | 27 |
| Total drug cost | $148,823 |
| Generic share | 51% of claims |
Industry payments (Open Payments)
- 2025$109,587 · 93 payments from 12 companies
- 2024$113,774 · 117 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $28,205 | 29 |
| Novo Nordisk As | $27,615 | 16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17,236 | 24 |
| Abbvie Inc. | $13,365 | 13 |
| Neurocrine Biosciences, Inc. | $12,296 | 2 |
What the 2025 payments were for
- Consulting Fee$76,757 · 27 payments
- Travel and Lodging$23,874 · 29 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$6,992 · 4 payments
- Food and Beverage$1,899 · 31 payments
- Education$64.54 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Arlington
- 1497340806
- 1861447740
- 1528475118
- 1447881909
- 1881649556
- 1992980619
- 1508804790
- 1730640855
- 1962437079
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Virginia →